I just received this email ----------------------
Post# of 9122
The following Press Release was Issued for the Purpose of Informing Those Potentially Interested in Association with NanoLogix and the Development and Use of the Newly Patented COVID-19 Detection Technology.
COVID-19 Rapid Test Patent Granted (einpresswire.com)
This update or press release contains statements, which may constitute "forward- looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
Further updates will occur as warranted.